A systematic review and meta-analysis of treatment-related toxicities of curative and palliative radiation therapy in non-small cell lung cancer
Abstract Treatment-related toxicity is an important component in non-small cell lung cancer
(NSCLC) management decision-making. Our aim was to evaluate and compare the toxicity …
(NSCLC) management decision-making. Our aim was to evaluate and compare the toxicity …
Lung cancer staging now and in the future
For a long time lung cancer was associated with a fatalistic approach by healthcare
professionals. In recent years, advances in imaging, improved diagnostic techniques and …
professionals. In recent years, advances in imaging, improved diagnostic techniques and …
Do multidisciplinary team meetings make a difference in the management of lung cancer?
BACKGROUND: There is limited evidence regarding the effectiveness of multidisciplinary
team (MDT) meetings in lung cancer. The objective of this study was to compare the patterns …
team (MDT) meetings in lung cancer. The objective of this study was to compare the patterns …
Characteristics and predictors of missed opportunities in lung cancer diagnosis: an electronic health record–based study
H Singh, K Hirani, H Kadiyala, O Rudomiotov… - Journal of Clinical …, 2010 - ascopubs.org
Purpose Understanding delays in cancer diagnosis requires detailed information about
timely recognition and follow-up of signs and symptoms. This information has been difficult …
timely recognition and follow-up of signs and symptoms. This information has been difficult …
[PDF][PDF] Clinico-pathological profile of lung cancer at AIIMS: a changing paradigm in India
Background: Lung cancer is one of the commonest and most lethal cancers throughout the
world. The epidemiological and pathological profile varies among different ethnicities and …
world. The epidemiological and pathological profile varies among different ethnicities and …
Stage III non-small cell lung cancer management in England
Aims We present the first analysis of the management and outcomes of stage III non-small
cell lung cancer (NSCLC) conducted in England using National Lung Cancer Audit data …
cell lung cancer (NSCLC) conducted in England using National Lung Cancer Audit data …
Multidisciplinary care in the oncology setting: historical perspective and data from lung and gynecology multidisciplinary clinics
LE Horvath, E Yordan, D Malhotra, I Leyva… - Journal of Oncology …, 2010 - ascopubs.org
Multidisciplinary care refers to a practice in which physicians from multiple specialties attend
to the same patient population. There are many advantages to the model, including reduced …
to the same patient population. There are many advantages to the model, including reduced …
Do multidisciplinary meetings follow guideline-based care?
Purpose: Multidisciplinary meetings (MDMs) are increasingly being mandated as essential
to oncology practice. However, there is a paucity of data on their effectiveness. The aim of …
to oncology practice. However, there is a paucity of data on their effectiveness. The aim of …
What's new in non-small cell lung cancer for pathologists: the importance of accurate subty**, EGFR mutations and ALK rearrangements
In the past, the only critical point of distinction in the pathological diagnosis of lung cancer
was between small cell and non-small cell lung cancer (NSCLC). The emergence of new …
was between small cell and non-small cell lung cancer (NSCLC). The emergence of new …
Development of a virtual multidisciplinary lung cancer tumor board in a community setting
MM Stevenson, T Irwin, T Lowry, MZ Ahmed… - Journal of Oncology …, 2013 - ascopubs.org
Purpose: Creating an effective platform for multidisciplinary tumor conferences can be
challenging in the rural community setting. The Duke Cancer Network created an Internet …
challenging in the rural community setting. The Duke Cancer Network created an Internet …